ARK Genomic Revolution ETFARKG
ARKG
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
13% more call options, than puts
Call options by funds: $109M | Put options by funds: $96.5M
0.96% more ownership
Funds ownership: 51.99% [Q4 2024] → 52.95% (+0.96%) [Q1 2025]
7% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 56
11% less funds holding
Funds holding: 234 [Q4 2024] → 208 (-26) [Q1 2025]
16% less capital invested
Capital invested by funds: $574M [Q4 2024] → $480M (-$94.3M) [Q1 2025]
44% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 41
Research analyst outlook
We haven’t received any recent analyst ratings for ARKG.
Financial journalist opinion
Positive
Seeking Alpha
5 days ago
ARKG: April's Wash-Out Low Is Encouraging, Healthcare Still Soft
I reiterate a soft buy rating on ARKG, despite recent sector weakness and mixed technicals, due to its rebound and improving valuation. ARKG stands out for its concentrated portfolio, high risk/reward profile, and focus on the genomics revolution, though it lacks a dividend yield. The ETF has rebounded 42% off April lows, outperforming the S&P 500, but faces seasonal headwinds and resistance near $28-$31.
Positive
24/7 Wall Street
1 month ago
Cathie Wood Comeback: These 2 Ark ETFs are Sailing Higher Again
It's probably time to give Cathie Wood the benefit of the doubt as the tides turn back in disruptive innovation's favor.
Neutral
Seeking Alpha
2 months ago
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Neutral
Seeking Alpha
5 months ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Positive
Zacks Investment Research
5 months ago
Best-Performing ETFs of Last Week
Wall Street was upbeat last week, despite the release of hot January inflation data.
Negative
24/7 Wall Street
5 months ago
2 Actively Managed ETFs That Got Smoked by the S&P 500 Last Year
Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years.
Positive
ETF Trends
5 months ago
Can Health Care ETFs Aid Your Portfolio?
The Health Care Select Sector SPDR ETF (XLV) was up approximately 6% year-to-date as of January 29. While it is still early days, this performance is already twice as robust as the sector ETF's performance for all of 2024.
Positive
24/7 Wall Street
5 months ago
Cathie Wood's Top Biotech Plays for February
Don't look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns.
Positive
ETF Trends
5 months ago
Under-the-Radar Opportunities in ETFs
Over recent years, investors have sought safety within mega-cap tech stocks while searching for alpha within disruptive technology trends like artificial intelligence. Most investors can agree the AI theme has long-term growth potential, and the current market sell-off is a short-term hiccup.
Neutral
ETF Trends
6 months ago
ETF Prime: Islam Shares 2025's Top Trends and ETFs
On this week's episode of ETF Prime, Roxanna Islam, CFA, CAIA, head of sector & industry research at VettaFi, joined host Nate Geraci. The two discussed top ETF performers and trends this year as well as long-established asset managers finally joining the ETF industry.
Charts implemented using Lightweight Charts™